Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of Parkinsonism with nigral hyperintensity. Issue 134 (January 2021)
- Record Type:
- Journal Article
- Title:
- Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of Parkinsonism with nigral hyperintensity. Issue 134 (January 2021)
- Main Title:
- Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of Parkinsonism with nigral hyperintensity
- Authors:
- Bae, Yun Jung
Song, Yoo Sung
Choi, Byung Se
Kim, Jong-Min
Nam, Yoonho
Kim, Jae Hyoung - Abstract:
- Highlights: Inter-observer agreement for nigral hyperintensity was higher for SMWI than for conventional SWI. SMWI showed significantly higher diagnostic performance for Parkinson's disease than SWI. SMWI showed higher concordance with 123 I-FP-CIT SPECT imaging than SWI. SMWI may be an important assessment tool in patients with suspected PD. Abstract: Objective: To determine whether susceptibility map-weighted imaging (SMWI) was superior to conventional susceptibility-weighted imaging (SWI) in the diagnosis of Parkinson's disease (PD) and in its correlation with 123 I-2bcarbomethoxy-3b-(4-iodophenyl)-N-(3-fluoropropyl)-nortropane single photon emission computerized tomography ( 123 I-FP-CIT SPECT). Methods: Between May 2017 and February 2018, 125 consecutive patients diagnosed with idiopathic PD, vascular pseudoparkinsonism, essential tremor, or drug-induced parkinsonism and who underwent 123 I-FP-CIT SPECT imaging and 3 T SWI on the same day or within 3 months were included in this retrospective study. In all patients, SMWI images were generated from SWI images. On both MRIs, two neuroradiologists independently evaluated the status of nigral hyperintensity on each side of substantia nigra. Inter-observer agreements for the nigral hyperintensity were tested. Using consensus reading, concordance between SWI, SMWI, and 123 I-FP-CIT SPECT were evaluated, and the diagnostic performance between SWI and SMWI for PD was compared. Results: Inter-observer agreement for the nigralHighlights: Inter-observer agreement for nigral hyperintensity was higher for SMWI than for conventional SWI. SMWI showed significantly higher diagnostic performance for Parkinson's disease than SWI. SMWI showed higher concordance with 123 I-FP-CIT SPECT imaging than SWI. SMWI may be an important assessment tool in patients with suspected PD. Abstract: Objective: To determine whether susceptibility map-weighted imaging (SMWI) was superior to conventional susceptibility-weighted imaging (SWI) in the diagnosis of Parkinson's disease (PD) and in its correlation with 123 I-2bcarbomethoxy-3b-(4-iodophenyl)-N-(3-fluoropropyl)-nortropane single photon emission computerized tomography ( 123 I-FP-CIT SPECT). Methods: Between May 2017 and February 2018, 125 consecutive patients diagnosed with idiopathic PD, vascular pseudoparkinsonism, essential tremor, or drug-induced parkinsonism and who underwent 123 I-FP-CIT SPECT imaging and 3 T SWI on the same day or within 3 months were included in this retrospective study. In all patients, SMWI images were generated from SWI images. On both MRIs, two neuroradiologists independently evaluated the status of nigral hyperintensity on each side of substantia nigra. Inter-observer agreements for the nigral hyperintensity were tested. Using consensus reading, concordance between SWI, SMWI, and 123 I-FP-CIT SPECT were evaluated, and the diagnostic performance between SWI and SMWI for PD was compared. Results: Inter-observer agreement for the nigral hyperintensity was higher for SMWI (right, κ = 0.919; left, κ = 0.984) than for SWI (right, κ = 0.918; left, κ = 0.902). SMWI (right 67.2 %, left 68.0 %) showed a higher concordance rate with the results of 123 I-FP-CIT SPECT than SWI (right 60.0 %, left 59.2 %). SMWI (area under curve [AUC], 0.791) provided significantly higher diagnostic performance for PD than SWI (AUC, 0.720; P = 0.0005). Conclusion: SMWI may be a superior assessment tool for nigral hyperintensity than SWI and may be an improved diagnostic imaging modality for patients with suspected PD. … (more)
- Is Part Of:
- European journal of radiology. Issue 134(2021)
- Journal:
- European journal of radiology
- Issue:
- Issue 134(2021)
- Issue Display:
- Volume 134, Issue 134 (2021)
- Year:
- 2021
- Volume:
- 134
- Issue:
- 134
- Issue Sort Value:
- 2021-0134-0134-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-01
- Subjects:
- Parkinson's disease -- Susceptibility-weighted imaging -- Susceptibility map-weighted imaging -- Nigral hyperintensity
Medical radiology -- Periodicals
Radiology -- Periodicals
Radiologie médicale -- Périodiques
Medical radiology
Periodicals
616.075705 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0720048X ↗
http://www.elsevier.com/homepage/elecserv.htt ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0720048X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0720048X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejrad.2020.109398 ↗
- Languages:
- English
- ISSNs:
- 0720-048X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.738050
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15401.xml